The global bioimpedance analyzers market is experiencing strong growth, driven by increasing demand for precise and non-invasive health monitoring solutions. Valued at USD 432.28 million in 2021, the market is projected to grow at a compound annual growth rate (CAGR) of 10.1%, reaching USD 1,019.20 million by 2030. Bioimpedance analyzers are widely used in hospitals,...